AstraZeneca
AZN
#47
Rank
NZ$485.44 B
Marketcap
NZ$156.57
Share price
0.17%
Change (1 day)
39.29%
Change (1 year)

AstraZeneca (AZN) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$56.65 Billion

According to AstraZeneca's latest financial reports the company's total debt is NZ$56.65 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AstraZeneca - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$53.39 B18.87%
2023-12-31NZ$44.91 B-2.14%
2022-12-31NZ$45.90 B2.17%
2021-12-31NZ$44.92 B59.07%
2020-12-31NZ$28.24 B4.36%
2019-12-31NZ$27.06 B-5.02%
2018-12-31NZ$28.49 B13.64%
2017-12-31NZ$25.07 B3.33%
2016-12-31NZ$24.26 B10.33%
2015-12-31NZ$21.99 B58.93%
2014-12-31NZ$13.83 B9.6%
2013-12-31NZ$12.62 B0.75%
2012-12-31NZ$12.53 B4.86%
2011-12-31NZ$11.95 B-0.01%
2010-12-31NZ$11.95 B-21.52%
2009-12-31NZ$15.23 B674%
2008-12-31NZ$1.96 B-90.05%
2007-12-31NZ$19.78 B1039.77%
2006-12-31NZ$1.73 B-1.2%
2005-12-31NZ$1.75 B-1.2%
2004-12-31NZ$1.77 B154.08%
2003-12-31NZ$0.69 B-56.6%
2002-12-31NZ$1.61 B-29.95%
2001-12-31NZ$2.30 B20.68%
2000-12-31NZ$1.90 B-10.91%
1999-12-31NZ$2.14 B-0.84%
1998-12-31NZ$2.15 B6.91%
1997-12-31NZ$2.01 B14.77%
1996-12-31NZ$1.75 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Bristol-Myers Squibb
BMY
NZ$88.61 B 56.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$105.64 B 86.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$71.83 B 26.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$41.42 B-26.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
NZ$44.32 B-21.76%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
NZ$73.79 B 30.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.50 B 40.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$22.46 B-60.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$11.44 B-79.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$55.59 B-1.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland